井寺制药

IDRA NASDAQ
2.570
-0.030
-1.15%
盘后: 2.570 0 0.00% 16:35 05/24 EDT
开盘
2.620
昨收
2.600
最高
2.690
最低
2.490
成交量
33.05万
成交均量(3M)
36.81万
52周最高
17.12
52周最低
2.250
换手率
1.18%
市值
7,201.59万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供井寺制药 IDRA股票价格,井寺制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The Company's drug candidates include IMO-8400, IMO-2125 and IMO-9200. The Company has designed TLR antagonists and agonists to act by modulating the activity of targeted TLRs. It is developing its 3GA technology to turn off the mRNA associated with disease causing genes.
展开 >

最近浏览

名称
价格
涨跌幅